High-protein yogurt brand Oikos is expanding beyond the dairy aisle with protein shakes geared to GLP-1 users, Danone North America shared exclusively with Axios
The insurer was paying $1,000 or more per month for medications that the majority of recipients would abandon within months, often without achieving the weight loss or metabolic improvements that justified the expense in the first place
Sandoz has been told its submission doesn't yet meet requirements and needs additional data pushing its expected launch from early 2026 to Q3 2026 at the earliest
Many prefer a gradual approach that aligns with their natural appetite rather than fighting against it
Carbonated beverages, sodas, and other fizzy drinks are full ofyou guessed itgas, so when you drink them, the gas eventually has to go somewhere
This could be because tirzepatide works through a dual mechanism targeting both GLP-1 and GIP receptors